SEC Form 4 · accession 0001209191-18-050944
CERNER CORP /MO/ · CERN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Zane M Burke
Officer — President
Period of report
Sep 11, 2018
Accepted (ET)
Sep 13, 2018 · 6:01 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000804753
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 11, 2018 | X | 14,600 | $60.37 | A | 59,539 | D | |
| Common Stock | Sep 11, 2018 | X | 84,000 | $54.01 | A | 143,539 | D | |
| Common Stock | Sep 11, 2018 | X | 140,000 | $55.74 | A | 283,539 | D | |
| Common StockF1,F2 | Sep 11, 2018 | S | 283,539 | $63.68 | D | 0 | D | |
| Common Stock | Sep 13, 2018 | X | 97,600 | $62.94 | A | 97,600 | D | |
| Common StockF1,F3 | Sep 13, 2018 | S | 97,600 | $65.14 | D | 0 | D | |
| Common Stock | holding | — | — | — | 13,290 | I | by 401(k) Plan |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F4 | $60.37 | Sep 11, 2018 | X | 14,600 | D | Mar 7, 2016 | Mar 7, 2024 | Common Stock | 14,600 | 0 | D |
| Non-Qualified Stock Option (right to buy)F4 | $54.01 | Sep 11, 2018 | X | 84,000 | D | Mar 11, 2018 | Mar 11, 2026 | Common Stock | 84,000 | 0 | D |
| Non-Qualified Stock Option (right to buy)F4 | $55.74 | Sep 11, 2018 | X | 140,000 | D | Mar 3, 2019 | Mar 3, 2027 | Common Stock | 140,000 | 0 | D |
| Non-Qualified Stock Option (right to buy)F4 | $62.94 | Sep 13, 2018 | X | 97,600 | D | Mar 2, 2020 | Mar 2, 2028 | Common Stock | 97,600 | 0 | D |
| Non-Qualified Stock Option (right to buy)F4 | $70.91 | holding | — | — | — | Mar 12, 2017 | Mar 12, 2025 | Common Stock | 73,000 | 73,000 | D |
Explanation of responses
- F1Full information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, Cerner Corporation, or a Cerner shareholder.
- F2Price reflects a weighted-average price for the transaction. Sale of shares took place at actual prices ranging from $63.11 to $64.10.
- F3Price reflects a weighted-average price for the transaction. Sale of shares took place at actual prices ranging from $65.00 to $65.40.
- F4On September 6, 2018, Mr. Burke became fully vested in all outstanding stock options as part of the terms of a Separation Agreement entered into with Cerner Corporation.